Perspective Therapeutics, Inc. (CATX)
USD 1.87
(0.81%)
USD 1.87
(0.81%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | -20.99 Million USD | 62.08% |
| 2021 | -55.36 Million USD | 12.19% |
| 2020 | -63.05 Million USD | -4445.93% |
| 2019 | -1.38 Million USD | 73.96% |
| 2018 | -5.32 Million USD | -104.85% |
| 2017 | -2.6 Million USD | 56.17% |
| 2016 | -5.93 Million USD | 41.49% |
| 2015 | -10.13 Million USD | -93.98% |
| 2014 | -5.22 Million USD | 31.94% |
| 2013 | -7.68 Million USD | -164.84% |
| 2012 | -2.89 Million USD | -8.5% |
| 2011 | -2.67 Million USD | -26.53% |
| 2010 | -2.11 Million USD | -40.92% |
| 2009 | -1.49 Million USD | 43.51% |
| 2008 | -2.65 Million USD | 39.49% |
| 2007 | -4.38 Million USD | 48.76% |
| 2006 | -8.55 Million USD | -1095.94% |
| 2005 | -715.57 Thousand USD | 97.8% |
| 2004 | -32.58 Million USD | 0.0% |
| 2002 | 100 Thousand USD | 0.0% |
| 2001 | 100 Thousand USD | -75.0% |
| 2000 | 400 Thousand USD | 1212221.21% |
| 1999 | -33.00 USD | -13.79% |
| 1998 | -29.00 USD | -100.02% |
| 1997 | 151.85 Thousand USD | -56.05% |
| 1996 | 345.54 Thousand USD | -36.86% |
| 1995 | 547.28 Thousand USD | -22.17% |
| 1994 | 703.21 Thousand USD | 61.73% |
| 1993 | 434.8 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q1 | -14.67 Million USD | 42.98% |
| 2022 FY | -20.99 Million USD | 62.08% |
| 2022 Q1 | -18.53 Million USD | 66.53% |
| 2022 Q2 | -20.6 Million USD | -11.17% |
| 2022 Q3 | -34.33 Million USD | -66.67% |
| 2022 Q4 | -25.74 Million USD | 25.03% |
| 2021 Q2 | -59.7 Million USD | 2.09% |
| 2021 Q4 | -55.36 Million USD | 5.06% |
| 2021 Q1 | -60.97 Million USD | 3.29% |
| 2021 FY | -55.36 Million USD | 12.19% |
| 2021 Q3 | -58.31 Million USD | 2.32% |
| 2020 Q4 | -63.05 Million USD | 1.49% |
| 2020 Q2 | -8.68 Million USD | -782.93% |
| 2020 Q1 | -984 Thousand USD | 29.06% |
| 2020 FY | -63.05 Million USD | -4445.93% |
| 2020 Q3 | -64 Million USD | -636.68% |
| 2019 Q4 | -1.38 Million USD | -3.28% |
| 2019 Q1 | -3.4 Million USD | 19.15% |
| 2019 FY | -1.38 Million USD | 73.96% |
| 2019 Q2 | -2.06 Million USD | 39.39% |
| 2019 Q3 | -1.34 Million USD | 34.87% |
| 2018 Q3 | -2.88 Million USD | 9.84% |
| 2018 Q1 | -2.19 Million USD | 15.65% |
| 2018 Q2 | -3.2 Million USD | -45.96% |
| 2018 Q4 | -4.2 Million USD | -45.81% |
| 2018 FY | -5.32 Million USD | -104.85% |
| 2017 Q4 | -2.6 Million USD | -9.94% |
| 2017 FY | -2.6 Million USD | 56.17% |
| 2017 Q3 | -2.36 Million USD | 19.86% |
| 2017 Q2 | -2.95 Million USD | 25.4% |
| 2017 Q1 | -3.95 Million USD | 33.31% |
| 2016 FY | -5.93 Million USD | 41.49% |
| 2016 Q3 | -5.1 Million USD | 23.52% |
| 2016 Q1 | -8.45 Million USD | 16.57% |
| 2016 Q4 | -5.93 Million USD | -16.31% |
| 2016 Q2 | -6.66 Million USD | 21.17% |
| 2015 FY | -10.13 Million USD | -93.98% |
| 2015 Q3 | -5.69 Million USD | -738.75% |
| 2015 Q2 | -678.9 Thousand USD | 57.22% |
| 2015 Q4 | -10.13 Million USD | -78.05% |
| 2015 Q1 | -1.58 Million USD | 69.64% |
| 2014 Q4 | -5.22 Million USD | -385.07% |
| 2014 Q2 | -1.33 Million USD | 35.58% |
| 2014 FY | -5.22 Million USD | 31.94% |
| 2014 Q1 | -2.07 Million USD | 72.98% |
| 2014 Q3 | -1.07 Million USD | 19.4% |
| 2013 FY | -7.68 Million USD | -164.84% |
| 2013 Q1 | -5.28 Million USD | -82.22% |
| 2013 Q4 | -7.68 Million USD | 67.6% |
| 2013 Q3 | -23.7 Million USD | -436.92% |
| 2013 Q2 | -4.41 Million USD | 16.46% |
| 2012 Q1 | -5.02 Million USD | -88.15% |
| 2012 Q2 | -4.44 Million USD | 11.69% |
| 2012 Q3 | -3.68 Million USD | 17.04% |
| 2012 Q4 | -2.89 Million USD | 21.29% |
| 2012 FY | -2.89 Million USD | -8.5% |
| 2011 Q4 | -2.67 Million USD | -5.88% |
| 2011 FY | -2.67 Million USD | -26.53% |
| 2011 Q3 | -2.52 Million USD | 25.34% |
| 2011 Q2 | -3.38 Million USD | -112.04% |
| 2011 Q1 | -1.59 Million USD | 24.51% |
| 2010 Q2 | -2.61 Million USD | -205.4% |
| 2010 Q3 | -2.52 Million USD | 3.44% |
| 2010 Q4 | -2.11 Million USD | 16.37% |
| 2010 FY | -2.11 Million USD | -40.92% |
| 2010 Q1 | -856.49 Thousand USD | 42.86% |
| 2009 Q3 | -2.23 Million USD | 23.02% |
| 2009 Q4 | -1.49 Million USD | 32.91% |
| 2009 FY | -1.49 Million USD | 43.51% |
| 2009 Q2 | -2.9 Million USD | -1.87% |
| 2009 Q1 | -2.84 Million USD | -7.38% |
| 2008 Q1 | -3.36 Million USD | 23.24% |
| 2008 Q4 | -2.65 Million USD | 44.74% |
| 2008 FY | -2.65 Million USD | 39.49% |
| 2008 Q3 | -4.8 Million USD | -129.32% |
| 2008 Q2 | -2.09 Million USD | 37.8% |
| 2007 Q1 | -5.71 Million USD | 33.23% |
| 2007 Q4 | -4.38 Million USD | -87.83% |
| 2007 Q2 | -2.8 Million USD | 50.88% |
| 2007 Q3 | -2.33 Million USD | 16.82% |
| 2007 FY | -4.38 Million USD | 48.76% |
| 2006 FY | -8.55 Million USD | -1095.94% |
| 2006 Q4 | -8.55 Million USD | 59.25% |
| 2006 Q2 | -2.33 Million USD | 37.64% |
| 2006 Q1 | -3.73 Million USD | -422.24% |
| 2006 Q3 | -21 Million USD | -801.23% |
| 2005 Q2 | 1.12 Million USD | -75.15% |
| 2005 FY | -715.57 Thousand USD | 97.8% |
| 2005 Q4 | -715.57 Thousand USD | 43.9% |
| 2005 Q3 | -1.27 Million USD | -213.12% |
| 2005 Q1 | 4.53 Million USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | -32.58 Million USD | 0.0% |
| 2004 Q3 | 4.52 Million USD | 113.87% |
| 2004 Q2 | -32.58 Million USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 FY | 100 Thousand USD | 0.0% |
| 2001 FY | 100 Thousand USD | -75.0% |
| 2001 Q1 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2000 Q3 | - USD | 100.0% |
| 2000 Q2 | -56.00 USD | -69.7% |
| 2000 Q1 | -33.00 USD | 42.11% |
| 2000 FY | 400 Thousand USD | 1212221.21% |
| 2000 Q4 | - USD | 0.0% |
| 1999 Q1 | -29.00 USD | 0.0% |
| 1999 Q2 | -105.00 USD | -262.07% |
| 1999 FY | -33.00 USD | -13.79% |
| 1999 Q3 | -81.00 USD | 22.86% |
| 1999 Q4 | -57.00 USD | 29.63% |
| 1998 FY | -29.00 USD | -100.02% |
| 1997 FY | 151.85 Thousand USD | -56.05% |
| 1996 FY | 345.54 Thousand USD | -36.86% |
| 1995 FY | 547.28 Thousand USD | -22.17% |
| 1994 FY | 703.21 Thousand USD | 61.73% |
| 1993 FY | 434.8 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Electromed, Inc. | -15.99 Million USD | -31.264% |
| Senseonics Holdings, Inc. | -27.93 Million USD | 24.842% |
| Catheter Precision, Inc. | -3.19 Million USD | -557.469% |
| Xtant Medical Holdings, Inc. | 17.63 Million USD | 219.035% |